NFKB1 and lung cancer: Bai’s research proved that GPR87 might participate in tumorigenesis and progression of lung cancer, which may also be related to immune infiltration (45).One study detected that GPR87, as an oncogene, is expressed in pancreatic cancer cells and promotes cancer proliferation and metastasis by driving the NF-κB signaling pathway (42).